Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05628207 · ClinicalTrials.gov registry record
Evaluation of the SCALED (SCaling AcceptabLE cDs)
A clinical trial of Traumatic Brain Injury and Venous Thromboembolism, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT05628207: Recruiting study of Traumatic Brain Injury and Venous Thromboembolism, sponsored by University of Minnesota.
NCT05628207 is a study of Traumatic Brain Injury and Venous Thromboembolism that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 15,000 participants, above the 190-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (7795% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05628207, a study of Traumatic Brain Injury and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previously implementing this guideline. The Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across 7 total institutions.
Primary Outcome
VTE event rate
Conditions Studied
Interventions
- OTHER Observational
- OTHER Observational-control
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2023-05-16 |
| Est. Completion | 2026-06-30 |
What NCT05628207 shows while recruiting
NCT05628207 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 190-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (7795% higher).
The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Observational is the first listed.
NCT05628207 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05628207 about?
NCT05628207 is a clinical study titled "Evaluation of the SCALED (SCaling AcceptabLE cDs)". This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previous...
What is the current status of trial NCT05628207?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2023-05-16. Estimated completion is 2026-06-30.
What conditions does trial NCT05628207 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Venous Thromboembolism.
What interventions are being tested in trial NCT05628207?
The interventions under investigation include: Observational (OTHER), Observational-control (OTHER).
Who is sponsoring clinical trial NCT05628207?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05628207 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05628207's enrollment target sits among peer trials
15,000 1st of 171 higher than 171 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI